[1]Patent:WO2012/162254,2012,A1.Locationinpatent:Page/Pagecolumn152-153
[2]JournalofMedicinalChemistry,2015,vol.58,p.5522-5537
[3]Patent:US2015/259331,2015,A1.Locationinpatent:Paragraph0193
[1]Patent:WO2012/162254,2012,A1
552330-87-7
16017-76-8 | 2-Chloro-6-hydroxy-7-methylpurine | AA001RN2 | MFCD00047225
17763-95-0 | Methanesulfonic acid, 1,1,1-trifluoro-, 1,1'-[1,1'-biphenyl]-2,2'-diyl ester | AA0025CT | MFCD00799480
18917-91-4 | Aluminum, tris[2-(hydroxy-κO)propanoato-κO]- | AA002HWX | MFCD20529175
290307-40-3 | 2-(5-Bromopyridin-2-yl)propan-2-ol | AA002V69 | MFCD11865230
607371-01-7 | 3-Bromo-n-ethyl-5-nitropyridin-4-amine | AA003712 | MFCD11046790
374067-51-3 | Diacetato[(R)-(+)-2,2'-bis(diphenylphosphino)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl]ruthenium(II) | AA003C94 | MFCD09753023
5255-33-4 | 4-Methyl-5-thiazoleacetic acid | AA003EU9 | MFCD01681551
1086138-36-4 | bis(2-(Di(adamantan-1-yl)phosphino)ethyl)amine | AA003O4Q | MFCD17018779
329736-05-2 | Dichloro[(S)-(-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]ruthenium(II) | AA003PAE | MFCD02684566
4972-49-0 | Meso-alpha,beta-di(4-pyridyl) glycol | AA003REK | MFCD00150314
